FDA's consumer safety officer, Jason Chancey, detailed real inspection findings, such as taped gaskets and delayed retesting, behind sterile facility deficiencies.
Jason F. Chancey
Advertisement
Jason F. Chancey, PharmD, is consumer safety officer for the Office of Manufacturing Quality at FDA’s CDER Office of Compliance.
Articles by Jason F. Chancey
Advertisement
Latest Updated Articles
FDA Highlights Aseptic Processing Pitfalls at PDA/FDA ConferenceSeptember 16th 2026
Advertisement
Advertisement
Trending on BioPharm International
1
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
2
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
3
FDA Grants Accelerated Approval to Ultomiris as First C5 Inhibitor for IgA Nephropathy
4
Alcon Pays $550 Million for Neurotech and Its MacTel Cell Therapy
5